Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

27.51
+0.07000.26%
Post-market: 27.47-0.0400-0.15%17:23 EDT
Volume:7.07M
Turnover:192.88M
Market Cap:6.42B
PE:-44.16
High:27.63
Open:27.41
Low:26.73
Close:27.44
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:0.80
T/O Rate:3.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:19.81
PE(LYR):53.70

Loading ...

Ratings Weekly | Tesla, Apple, Alphabet, Amazon, Intel, AMD, Texas Instruments, and More to Watch

Tiger Newspress
·
Apr 25

Is Hims & Hers Health (HIMS) Pricing Reflect Fast-Growing Telehealth Hype Or Business Fundamentals

Simply Wall St.
·
Apr 25

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications

Reuters
·
Apr 25

Bullish flow in Hims and Hers Health with shares up 9.2%

TIPRANKS
·
Apr 25

BUZZ-U.S. STOCKS ON THE MOVE-Zoom, Compass Pathways,  X-Energy

Reuters
·
Apr 24

Now Is the Time to Buy Hims & Hers Stock (HIMS), Says JPMorgan Chase

TIPRANKS
·
Apr 24

Stock Track | Hims & Hers Health Soars 6.22% Intraday on J.P. Morgan's Bullish Initiation and GLP-1 Drug Launch

Stock Track
·
Apr 24

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
Apr 24

Stock Track | Hims & Hers Health Soars 5.04% in Pre-market After J.P. Morgan Initiates Coverage with Overweight Rating

Stock Track
·
Apr 24

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, World Kinect, Procter & Gamble

Reuters
·
Apr 24

JPMorgan Initiates Coverage on Hims & Hers Health With Overweight Rating, $35 Price Target

MT Newswires Live
·
Apr 24

BUZZ-Hims & Hers Health rises after J.P. Morgan initiates coverage with 'overweight' rating

Reuters
·
Apr 24

Hims & Hers Health Shares up 2.2% Premarket After JP Morgan Initiates Coverage With Overweight Rating

THOMSON REUTERS
·
Apr 24

Eli Lilly (LLY) Expands Partnership with Hims & Hers

TIPRANKS
·
Apr 24

Stock Track | Hims & Hers Health Plummets 5.03% Intraday as It Yields Ground in Competitive GLP-1 Market

Stock Track
·
Apr 24

Hims & Hers likely to be up on LillyDirect announcement, says Leerink

TIPRANKS
·
Apr 24

Hims & Hers Positions Itself As Supply Anchor In Hormone Therapy Crunch

Benzinga_recent_news
·
Apr 24

Hims Yields Ground in GLP-1 Market. Why Its CEO Is Calling It the Netflix of Pharma. -- Barrons.com

Dow Jones
·
Apr 23

Hims & Hers Health Soars over 6% on FDA-Approved GLP-1 Treatment Expansion

Stock Track
·
Apr 23

Hims&Hers on FDA-Approved Glp-1 Treatments: Providers Delivering Ongoing Care to Hims & Hers Customers Can Prescribe Medications That Are Fulfilled by Independent Pharmacies

THOMSON REUTERS
·
Apr 23